SE7904216L - Di-o-n-alkylglycerolderivat med immunitetsstimulerande verkan - Google Patents

Di-o-n-alkylglycerolderivat med immunitetsstimulerande verkan

Info

Publication number
SE7904216L
SE7904216L SE7904216A SE7904216A SE7904216L SE 7904216 L SE7904216 L SE 7904216L SE 7904216 A SE7904216 A SE 7904216A SE 7904216 A SE7904216 A SE 7904216A SE 7904216 L SE7904216 L SE 7904216L
Authority
SE
Sweden
Prior art keywords
derivatives
alkylgycerol
stimulating effects
immunity stimulating
immunity
Prior art date
Application number
SE7904216A
Other languages
English (en)
Other versions
SE429966B (sv
Inventor
A R Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7904216L publication Critical patent/SE7904216L/sv
Publication of SE429966B publication Critical patent/SE429966B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7904216A 1978-05-15 1979-05-14 Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta SE429966B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/906,260 US4173641A (en) 1978-05-15 1978-05-15 Di-O-n-alkyl glycerol derivatives as immune stimulants

Publications (2)

Publication Number Publication Date
SE7904216L true SE7904216L (sv) 1979-11-16
SE429966B SE429966B (sv) 1983-10-10

Family

ID=25422164

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904216A SE429966B (sv) 1978-05-15 1979-05-14 Di-0-n-alkylglycerolderivat med immunitetsstimulerande verkan och farmaceutiska beredningar innehallande detta

Country Status (38)

Country Link
US (1) US4173641A (sv)
JP (2) JPS5924974B2 (sv)
AR (1) AR221724A1 (sv)
AT (1) AT372678B (sv)
AU (1) AU513771B2 (sv)
BE (1) BE876229A (sv)
CA (1) CA1105935A (sv)
CH (1) CH639939A5 (sv)
DD (1) DD144540A5 (sv)
DE (1) DE2919514C2 (sv)
DK (1) DK149946C (sv)
EG (1) EG15252A (sv)
ES (1) ES480565A1 (sv)
FI (1) FI69450C (sv)
FR (1) FR2426039A1 (sv)
GB (1) GB2021580B (sv)
GR (1) GR72419B (sv)
GT (1) GT197957869A (sv)
HK (1) HK13584A (sv)
HU (1) HU180283B (sv)
IE (1) IE48229B1 (sv)
IL (1) IL57268A (sv)
IN (1) IN150574B (sv)
IT (1) IT1115217B (sv)
KE (1) KE3354A (sv)
LU (1) LU81253A1 (sv)
MY (1) MY8500096A (sv)
NL (1) NL175524C (sv)
NO (1) NO151285C (sv)
NZ (1) NZ190444A (sv)
PH (1) PH15256A (sv)
PL (1) PL123910B1 (sv)
PT (1) PT69607A (sv)
SE (1) SE429966B (sv)
SG (1) SG65483G (sv)
SU (1) SU1122220A3 (sv)
YU (1) YU41156B (sv)
ZA (1) ZA792306B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
US4310550A (en) * 1979-10-26 1982-01-12 Pfizer Inc. Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
US4395394A (en) * 1979-10-26 1983-07-26 Pfizer Inc. Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
WO2011076807A2 (en) 2009-12-23 2011-06-30 Novartis Ag Lipids, lipid compositions, and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
US3432602A (en) * 1967-12-20 1969-03-11 Astra Ab Oral alkyl glycerol ether improvement in radiation,radiomimetic,or cytostatic tumor therapies
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4069223A (en) * 1977-05-02 1978-01-17 G. D. Searle & Co. 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols

Also Published As

Publication number Publication date
DD144540A5 (de) 1980-10-22
NO791604L (no) 1979-11-16
PH15256A (en) 1982-11-02
IT1115217B (it) 1986-02-03
AU4701679A (en) 1979-11-22
NL175524C (nl) 1984-11-16
CH639939A5 (fr) 1983-12-15
GT197957869A (es) 1980-11-04
PT69607A (en) 1979-06-01
DE2919514C2 (de) 1982-06-03
AT372678B (de) 1983-11-10
JPS5924974B2 (ja) 1984-06-13
BE876229A (fr) 1979-11-14
US4173641A (en) 1979-11-06
CA1105935A (en) 1981-07-28
MY8500096A (en) 1985-12-31
JPS58131947A (ja) 1983-08-06
FI69450C (fi) 1986-02-10
SG65483G (en) 1984-07-27
YU41156B (en) 1986-12-31
HK13584A (en) 1984-02-24
ATA356179A (de) 1983-03-15
FR2426039B1 (sv) 1983-12-16
IE48229B1 (en) 1984-11-14
HU180283B (en) 1983-02-28
NZ190444A (en) 1981-05-29
DE2919514A1 (de) 1979-11-22
AR221724A1 (es) 1981-03-13
GB2021580B (en) 1982-09-08
LU81253A1 (fr) 1979-12-07
ZA792306B (en) 1980-05-28
GR72419B (sv) 1983-11-03
ES480565A1 (es) 1980-08-16
FR2426039A1 (fr) 1979-12-14
IN150574B (sv) 1982-11-13
GB2021580A (en) 1979-12-05
NO151285B (no) 1984-12-03
NO151285C (no) 1985-03-13
IE790938L (en) 1979-11-15
IL57268A0 (en) 1979-09-30
KE3354A (en) 1983-12-16
IL57268A (en) 1982-05-31
PL123910B1 (en) 1982-12-31
JPS6139301B2 (sv) 1986-09-03
AU513771B2 (en) 1980-12-18
PL215573A1 (sv) 1980-07-01
YU109479A (en) 1983-02-28
DK149946C (da) 1987-06-15
FI69450B (fi) 1985-10-31
NL7903769A (nl) 1979-11-19
JPS55378A (en) 1980-01-05
FI791531A (fi) 1979-11-16
DK149946B (da) 1986-11-03
SU1122220A3 (ru) 1984-10-30
SE429966B (sv) 1983-10-10
IT7922664A0 (it) 1979-05-14
DK102479A (da) 1979-11-16
EG15252A (en) 1986-09-30

Similar Documents

Publication Publication Date Title
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
JPS5412372A (en) Thiazolidine derivative and its preparation
BE849627A (fr) Derives d'indol substitues par des bases, leur preparation de preparation et leurs applications
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
FR2275210A1 (fr) Nouveaux derives de benzimidazolinone
SE7904216L (sv) Di-o-n-alkylglycerolderivat med immunitetsstimulerande verkan
FI850449A0 (fi) Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
ES492578A0 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
AR217240A1 (es) Procedimiento para preparar derivados acilamino sustituidos de 1,2,4-oxadiazol,1,3-4-oxadiazol,1,2,4-tiadiazol y 1,3,4-tiadiazol,terapeuticamente utiles
FR2332747A1 (fr) Derives d'a-aminocetones
FR2322604A1 (fr) Derives 3-triazolylthio d'ureido-7a-methoxy-ou demethoxycephalosporines
BE877694A (fr) Derives de 1-phenyl-1-propanol.
RO81506A (ro) Procedeu pentru prepararea derivatilor acizilor 1,3,4-tiadiazol-2-carboxilici
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
FR2301267A1 (fr) Obtention d'enz
SE7713587L (sv) Forfarande for framstellning av oxazolidindionderivat av vinkaalkaloider
SE7809831L (sv) Forfarande for framstellning av barrvedsmassa
FR2313365A1 (fr) Preparation de derives de l'indole
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
FR2331330A1 (fr) Derives d'ethanolamines
FI793613A (fi) Framstaellning av etylenkopolymerer med hoeg densitet i en fluidationsbaeddreaktor
FR2303547A1 (fr) Derives de l'isoquinoleine
TR20895A (tr) 1,2,3-tiyadiyazol-5-yl uerelerinin hazirlanmasina mahsus usul

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7904216-4

Effective date: 19931210

Format of ref document f/p: F